PYXS · Pyxis Oncology, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Positioning
Aug 21, 2026 · 1 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 563 | 57 | — | — | $0.94 | $0.05 | -0.157 | 547.1% | 486 | 831 | |
| 228 | 1 | 560.9% | 0.202 | $0.02 | $2.60 | -0.695 | 755.6% | 5 | 108 | |
| 50 | 4 | — | — | $0.07 | — | -0.802 | 991.2% | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Aug 10, 2026–Aug 19, 2026; 1 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.